Clinical Trial Update: A Study to Compare Fluticasone /Formoterol Breath Actuated Inhaler (BAI) and Ultibro in Subjects With Fixed Airflow Obstruction and Elevated Eosinophils [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing fluticasone propionate/formoterol (BAI) versus indacaterol/glycopyrronium (Ultibro) in ACOS with fixed airflow obstruction and eleva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma-copd Overlap

Drugs mentioned

• Fluticasone propionate/formoterol (Breath Actuated Inhaler) (Fluticasone propionate/formoterol)
• Indacaterol/glycopyrronium (Indacaterol + glycopyrronium)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: ACOS (Fixed Airflow Obstruction and Elevated Eosinophils) | Phase 2, Phase 3 | Status: TERMINATED